PRESS RELEASES

Date	Title and Summary	Additional Formats
Toggle SummaryAug 3, 2015	Integra LifeSciences Announces Proposed Public Offering of Common Stock PLAINSBORO, N.J., Aug. 3, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it intends to offer, subject to market conditions and other factors, $200,000,000 of its common stock in an underwritten public offering registered under the Securities	View HTML Integra LifeSciences Announces Proposed Public Offering of Common Stock 14 KB
Toggle SummaryJul 30, 2015	Integra LifeSciences Reports Second Quarter 2015 Financial Results Revenue Increased 5.5% to $244.1 Million Reported EPS of $0.15; Adjusted EPS Increased 16% to $0.79 Full Year 2015 Revenue and EPS Guidance Updated for SeaSpine Spin-off and TEI Acquisition PLAINSBORO, N.J., July 30, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART)	View HTML Integra LifeSciences Reports Second Quarter 2015 Financial Results 47 KB
Toggle SummaryJul 20, 2015	Integra LifeSciences Completes Acquisition of TEI Biosciences and TEI Medical PLAINSBORO, N.J., July 20, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), today announced that it has completed the acquisition of all of the outstanding shares of TEI Biosciences Inc. and TEI Medical Inc. ("TEI"). "We are enthusiastic about the strategic fit of	View HTML Integra LifeSciences Completes Acquisition of TEI Biosciences and TEI Medical 12.7 KB
Toggle SummaryJul 15, 2015	Integra LifeSciences to Host Its Second Quarter 2015 Earnings Results Conference Call on July 30, 2015 PLAINSBORO, N.J., July 15, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) will release its second quarter 2015 financial results on Thursday, July 30, 2015. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the results.	View HTML Integra LifeSciences to Host Its Second Quarter 2015 Earnings Results Conference Call on July 30, 2015 10.1 KB
Toggle SummaryJul 1, 2015	Integra LifeSciences Completes Spin-Off of SeaSpine PLAINSBORO, N.J., July 1, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it has completed the previously announced tax-free spin-off of its orthobiologics and spinal fusion hardware business, now known as SeaSpine Holdings Corporation	View HTML Integra LifeSciences Completes Spin-Off of SeaSpine 10 KB
Toggle SummaryJun 28, 2015	Integra LifeSciences to Acquire TEI Biosciences and TEI Medical Broadens Integra's position as a leader in regenerative wound care and tissue repair Adds new selling capabilities to the wound care clinic and enhances current sales channel in both burn centers and Operating Rooms (OR) Management to Host Conference Call Tomorrow PLAINSBORO, N.J.	View HTML Integra LifeSciences to Acquire TEI Biosciences and TEI Medical 18.2 KB
Toggle SummaryJun 9, 2015	Integra to Complete Tax-Free Spin-Off of SeaSpine on July 1, 2015 Declares Record Date of June 19, 2015 and Share Distribution Date of July 1, 2015	View HTML Integra to Complete Tax-Free Spin-Off of SeaSpine on July 1, 2015 16.1 KB
Toggle SummaryJun 4, 2015	Richard Gorelick, Corporate Vice President and General Counsel of Integra LifeSciences, Named NJBIZ General Counsel of the Year Winner PLAINSBORO, N.J., June 4, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the Richard Gorelick, Corporate Vice President, General Counsel, Administration and Secretary, was named as 2015 NJBIZ General Counsel of the Year of public companies with	View HTML Richard Gorelick, Corporate Vice President and General Counsel of Integra LifeSciences, Named NJBIZ General Counsel of the Year Winner 10.2 KB
Toggle SummaryMay 26, 2015	Integra LifeSciences and SeaSpine to Present at the Jefferies 2015 Global Healthcare Conference in June PLAINSBORO, N.J., May 26, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will make the following presentations at the Jefferies 2015 Global Healthcare Conference in New York City: At 4:00PM ET on Tuesday, June 2, 2015, Mr.	View HTML Integra LifeSciences and SeaSpine to Present at the Jefferies 2015 Global Healthcare Conference in June 13.6 KB
Toggle SummaryMay 20, 2015	Integra LifeSciences to Provide Historical Financials Adjusted for Discontinued Operations and Host Conference Call on May 26, 2015 PLAINSBORO, N.J., May 20, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced plans to release historical financial information adjusted for the planned spin-off of its spine business, to become SeaSpine Holdings Corporation.	View HTML Integra LifeSciences to Provide Historical Financials Adjusted for Discontinued Operations and Host Conference Call on May 26, 2015 15.2 KB
Toggle SummaryMay 13, 2015	SeaSpine to Join Integra LifeSciences at the 2015 UBS Global Healthcare Conference PLAINSBORO, N.J., May 13, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Keith Valentine, Chief Executive Officer of SeaSpine, will join Integra to present at the 2015 UBS Global Healthcare Conference.	View HTML SeaSpine to Join Integra LifeSciences at the 2015 UBS Global Healthcare Conference 13.3 KB
Toggle SummaryMay 1, 2015	Integra LifeSciences Features New MAYFIELD(R) 2 System at the American Association of Neurological Surgeons Annual Scientific Meeting PLAINSBORO, N.J., May 1, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the introduction of the new MAYFIELD ® 2 system for rigid cranial fixation. The MAYFIELD 2 system will be featured at the Integra LifeSciences exhibition booth at the American	View HTML Integra LifeSciences Features New MAYFIELD(R) 2 System at the American Association of Neurological Surgeons Annual Scientific Meeting 11.8 KB
Toggle SummaryApr 30, 2015	Integra LifeSciences Reports First Quarter 2015 Financial Results Revenue Increased 8.7% to $233.7 Million Reported EPS Increased to $0.25; Adjusted EPS Increased to $0.76 Full Year 2015 Revenue and EPS Guidance Raised PLAINSBORO, N.J., April 30, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results	View HTML Integra LifeSciences Reports First Quarter 2015 Financial Results 50.3 KB
Toggle SummaryApr 30, 2015	Integra LifeSciences Names Keith Valentine as Chief Executive Officer of SeaSpine; John Bostjancic Appointed as Chief Financial Officer of SeaSpine PLAINSBORO, N.J., April 30, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the appointment, effective May 1, 2015, of Keith Valentine as Chief Executive Officer of SeaSpine Holdings Corporation, which will be an independent, publicly traded company	View HTML Integra LifeSciences Names Keith Valentine as Chief Executive Officer of SeaSpine; John Bostjancic Appointed as Chief Financial Officer of SeaSpine 15.3 KB
Toggle SummaryApr 20, 2015	Integra LifeSciences to Participate in Three Investor Conferences in May PLAINSBORO, N.J., April 20, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will present at the following conferences in May: At 2:10PM ET on Wednesday, May 6, 2015, Glenn Coleman, Integra's Chief Financial Officer, will present at the	View HTML Integra LifeSciences to Participate in Three Investor Conferences in May 10.6 KB